Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase III Study for the Treatment of Newly Diagnosed Disseminated Lymphoblastic Lymphoma or Localized Lymphoblastic Lymphoma

NCT00004228 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00004228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase III Study for the Treatment of Newly Diagnosed Disseminated Lymphoblastic Lymphoma or Localized Lymphoblastic Lymphoma
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2000
Completion date
March 31, 2015
Enrollment
393 (actual)
Sites
176

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma